2025-11-15 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG) based on the data you provided.  The report is in English and includes numerical data with analysis.

**Report on Intuitive Surgical Inc. (ISRG)**

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return ISRG:** 103.91%
*   **Cumulative Return VOO:** 98.45%
*   **Outperformance:** ISRG has outperformed VOO by 5.46% (103.91 - 98.45) over the period.
*   **Relative Divergence:** The relative divergence is currently at 29.3, indicating that ISRG's performance is positioned in the lower quartile of its historical range relative to the S&P 500.  This suggests potential for further upside relative to the market, but it's important to note that this is based on historical data.
*   **Divergence Range:** (max: 98.9, min: -37.8, 현재: 2.3)

**Alpha/Beta Analysis Table:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 68.0% | 77.6% | 41.0% | -0.1 | 44.4   |
| 2016-2018  | 64.0% | 72.2% | 48.0% | -0.0 | 58.2   |
| 2017-2019  | 54.0% | 72.2% | 31.0% | 0.2  | 71.9   |
| 2018-2020  | -6.0% | 80.4% | -29.0% | 0.2  | 99.5   |
| 2019-2021  | 29.0% | 80.4% | -18.0% | 0.5  | 131.1  |
| 2020-2022  | -23.0% | 80.4% | -22.0% | 1.2  | 96.8   |
| 2021-2023  | -17.0% | 77.5% | -18.0% | 1.7  | 123.1  |
| 2022-2024  | 36.0% | 77.5% | 15.0% | 1.7  | 190.4  |
| 2023-2025  | 66.0% | 72.7% | 3.0%  | 0.8  | 200.5  |

*   **Analysis:**
    *   **CAGR:** The Compound Annual Growth Rate (CAGR) varies significantly across different periods, indicating volatile growth. Recent periods (2023-2025) show strong growth.
    *   **MDD:** Maximum Drawdown (MDD) is consistently high, suggesting significant risk or volatility in the stock's price.
    *   **Alpha:** Alpha, representing excess return compared to the benchmark, has fluctuated from positive to negative, suggesting periods of both outperformance and underperformance. The most recent period (2023-2025) shows a positive alpha.
    *   **Beta:** Beta has generally increased over time, indicating that ISRG's price movements are becoming more correlated with the overall market (S&P 500).
    *   **Market Cap:** The market capitalization has grown significantly over time, reflecting the company's overall growth.

**2. Recent Stock Price Action**

*   **Current Price:** 549.51
*   **Previous Close:** 565.51
*   **Change:** -2.83% (Significant decrease from the previous close)
*   **5-Day Moving Average:** 567.17
*   **20-Day Moving Average:** 540.96
*   **60-Day Moving Average:** 479.51

*   **Analysis:** The current price is below the 5-day moving average, suggesting potential short-term downward momentum. However, it's above both the 20-day and 60-day moving averages, indicating that the intermediate and long-term trends are still upward.  The large negative change (-2.83%) from the previous close indicates a recent sharp drop, potentially due to news or market sentiment.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 49.10 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.2394 (Slightly negative, suggesting potential for upward movement)
*   **Delta_Previous_Relative_Divergence:** 3.8 (+): 단기상승 (Short-term increase)
*   **Hybrid Signal:**  cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03) - Suggests a buy signal.
*   **Expected Return:** 29.1% (Long-term projected outperformance vs. S&P 500)

*   **Analysis:** The MRI suggests a medium-risk investment. The RSI being near 50 is neutral. The positive Delta_Previous_Relative_Divergence indicates a recent short-term improvement in performance relative to its history. The Hybrid Signal suggests a buying opportunity. The significant drop in price today, as evidenced by the -2.83% change, should be considered in context with these other indicators. The strong expected return suggests that despite short-term volatility, the long-term outlook remains positive.

**4. Recent News & Significant Events (Yahoo Finance)**

*   **Key Headlines:**
    *   Valuation concerns after earnings (Insider Monkey)
    *   31% stock increase since October lows (Investor's Business Daily)
    *   Debate on whether to sell shares (Motley Fool)
    *   Bullish technical assessment (Argus Research)
    *   Insider selling of shares (MT Newswires)

*   **Analysis:** The news is mixed. Positive earnings and technical assessments are countered by valuation concerns, the "sell shares" debate, and insider selling.  Insider selling can sometimes be a negative signal, but it doesn't always indicate a problem with the company's fundamentals. The mixed news environment suggests caution.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean Rating: 2.00)
*   **Target Price:** Average: $592.96, High: $700.00, Low: $378.00
*   **Recent Rating Changes:** No recent changes provided.

*   **Analysis:**  Analysts generally have a positive outlook on ISRG. The average target price suggests a potential upside from the current price. The wide range between high and low target prices indicates varying degrees of optimism/pessimism among analysts.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue        |
|------------|------|----------------|
| 2025-10-22 | 1.98 | 2.51 B$        |
| 2025-07-23 | 1.84 | 2.44 B$        |
| 2025-04-23 | 1.95 | 2.25 B$        |
| 2024-10-18 | 1.59 | 2.04 B$        |
| 2025-10-22 | 1.59 | 2.04 B$        |

*   **Analysis:**  Both EPS and revenue have generally been increasing over the last few quarters, indicating positive growth momentum. The duplication of the 2025-10-22 and 2024-10-18 results needs to be corrected for a more accurate analysis. However, assuming the 2025-10-22 data is accurate, the company appears to be performing well.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $2.51B     | 66.36%        |
| 2025-06-30   | $2.44B     | 66.31%        |
| 2025-03-31   | $2.25B     | 64.69%        |
| 2024-12-31   | $2.41B     | 68.04%        |
| 2024-09-30   | $2.04B     | 67.41%        |

**Capital and Profitability**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30   | $16.93B    | 4.16%    |
| 2025-06-30   | $17.85B    | 3.69%    |
| 2025-03-31   | $17.11B    | 4.08%    |
| 2024-12-31   | $16.43B    | 4.17%    |
| 2024-09-30   | $15.58B    | 3.63%    |

*   **Analysis:**
    *   **Revenue and Profitability:** Revenue has shown consistent growth over the past few quarters, and profit margins remain strong, indicating efficient operations and pricing power.
    *   **Capital and Profitability:** Equity has generally increased, reflecting the company's retained earnings. ROE (Return on Equity) has fluctuated but remains at a healthy level, indicating good profitability relative to shareholder equity.

**7. Overall Summary**

Intuitive Surgical (ISRG) presents a mixed picture:

*   **Strengths:** The company has strong fundamentals, including growing revenue, high profit margins, positive analyst ratings, and a substantial long-term expected return relative to the S&P 500. The company's recent earnings performance also appears to be strong.
*   **Weaknesses/Risks:**  The stock experienced a significant drop today, potentially influenced by valuation concerns highlighted in recent news, as well as insider selling. The high MDD figures indicate significant volatility.
*   **Overall:** ISRG appears to be a growth-oriented company with strong long-term potential. However, investors should be aware of the potential for short-term volatility and carefully consider the valuation concerns and recent insider selling activity. The medium MRI suggests a reasonable level of risk. The recent price drop may present a buying opportunity for long-term investors, but further research and due diligence are recommended.
